Literature DB >> 3123397

The complement membrane attack complex stimulates the prostanoid production of cultured glomerular epithelial cells.

G M Hänsch1, M Betz, J Günther, K O Rother, B Sterzel.   

Abstract

Incubation of cultured rat glomerular epithelial cells (GEC) with sublytic amounts of the purified complement components C5b6, C7, C8 and C9 greatly stimulated the release of the prostanoids prostaglandin E (PGE) and thromboxane B2. Incubation of GEC with C5b-8 was also stimulatory, whereas omission of C7 abolished the enhanced prostanoid production. These effects were dose-dependent. The increased release of PGE was biphasic with peaks at 5 min and 24 h of incubation. The second peak could be prevented by treatment with cycloheximide, suggesting its dependence on protein synthesis. The observations on cultured GEC provide evidence that terminal complement components alter the metabolism of glomerular cells, resulting in increased production of prostanoids. The results are consistent with the concept that deposition of nonlytic amounts of complement in the glomerular capillary wall may affect the GEC in vivo and may indirectly contribute to abnormalities of the glomerular filter as it is seen in glomerular disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3123397     DOI: 10.1159/000234479

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  12 in total

Review 1.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

2.  Interaction of the terminal complement components C5b-9 with synovial fibroblasts: binding to the membrane surface leads to increased levels in collagenase-specific mRNA.

Authors:  B Jahn; J Von Kempis; K L Krämer; S Filsinger; G M Hänsch
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

Review 3.  Membrane signaling by complement C5b-9, the membrane attack complex.

Authors:  A Nicholson-Weller; J A Halperin
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

4.  Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats.

Authors:  P J Baker; R F Ochi; M Schulze; R J Johnson; C Campbell; W G Couser
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

5.  The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells.

Authors:  I A Rooney; A Davies; D Griffiths; J D Williams; M Davies; S Meri; P J Lachmann; B P Morgan
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

6.  Protection of human amniotic epithelial cells (HAEC) from complement-mediated lysis: expression on the cells of three complement inhibitory membrane proteins.

Authors:  I A Rooney; B P Morgan
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

7.  Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis.

Authors:  Susanna H Weerth; Horea Rus; Moon L Shin; Cedric S Raine
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

8.  Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain.

Authors:  J Floege; R J Johnson; C E Alpers; S Fatemi-Nainie; C A Richardson; K Gordon; W G Couser
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

9.  The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells.

Authors:  K S Kilgore; C M Flory; B F Miller; V M Evans; J S Warren
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

10.  Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis.

Authors:  C J Pruchno; M M Burns; M Schulze; R J Johnson; P J Baker; C E Alpers; W G Couser
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.